A. Chehaider

Immune-mediated cutaneous leukocytoclastic vasculitis followed by a severe acute infusion reaction after infliximab rechallenge in Crohn’s disease: a case report and review of the literature

Infliximab is widely used for Crohn’s disease (CD). Despite its efficacy, it may be associated with immune-mediated adverse events, including cutaneous vasculitis and acute infusion reactions. The temporal association between these events is clinically important and should be int...